James Milbauer, MD
NPI 1598744450 · Specialist · Parsippany, NJ
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
James Milbauer, MD is a Specialist provider in Parsippany, NJ (NPI 1598744450).
Provider details
- NPI number
- 1598744450
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- MD
- Sex
- Male
- License
- 25MA04708500 (NJ)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,257 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 608 | $59 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 248 | $7 |
| Biopsy of Related Skin Growth, First Growth11102 | 140 | $104 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 132 | $63 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 | 42 | $53 |
| Punch Biopsy, First Skin Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 66 | 30 |
| Fluorouracil | 34 | 31 |
| Ciclopirox Olaminebrand: Ciclopirox | 23 | — |
| Azelaic Acid | 23 | 13 |
| Doxycycline Hyclate | 22 | — |
| Valacyclovir Hclbrand: Valacyclovir | 22 | 12 |
| Triamcinolone Acetonide | 21 | 15 |
| Doxycycline Monohydrate |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$145 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-10
- Last updated
- 2007-07-08
Frequently asked questions
- What is James Milbauer's NPI number?
- James Milbauer's National Provider Identifier (NPI) is 1598744450, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is James Milbauer's specialty?
- James Milbauer is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is James Milbauer located?
- James Milbauer's practice location on file with NPPES is 50 Cherry Hill Rd, Parsippany, NJ 07054-1101.
- What is James Milbauer's phone number?
- The practice phone number listed in the NPPES registry for James Milbauer is (973) 335-1516.
- Does James Milbauer accept Medicare?
- James Milbauer is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is James Milbauer's NPI active?
- Yes — James Milbauer's NPI (1598744450) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.